Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Short-Term Bond ETF
BSV
|
+$1.77B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.52B |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$1.18B |
| 4 |
iShares Russell 1000 Growth ETF
IWF
|
+$947M |
| 5 |
Zoetis
ZTS
|
+$787M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$2.39B |
| 2 |
NVIDIA
NVDA
|
+$2.32B |
| 3 |
Microsoft
MSFT
|
+$2.06B |
| 4 |
Apple
AAPL
|
+$1.62B |
| 5 |
Vanguard Total Bond Market
BND
|
+$1.51B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.47% |
| 2 | Financials | 11.66% |
| 3 | Consumer Discretionary | 8.63% |
| 4 | Communication Services | 7.31% |
| 5 | Healthcare | 7.25% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
5026
Critical Metals Corp
CRML
$887M
| $889K | ﹤0.01% |
248,188
+177,474
| +251% | +$324K |
|
5027
Biote Corp
BTMD
$70.7M
| $887K | ﹤0.01% |
220,682
+103,140
| +88% | +$381K |
|
5028
SoundThinking
SSTI
$109M
| $885K | ﹤0.01% |
67,763
+2,607
| +4% | +$40.6K |
|
5029
Liberty Latin America Class A
LILA
$1.57B
| $884K | ﹤0.01% |
213,312
-72,306
| -25% | -$262K |
|
5030
Virtus Biotech ETF
BBP
$97.3M
| $884K | ﹤0.01% |
15,177
+6,156
| +68% | +$348K |
|
|
HSHP
5031
Himalaya Shipping
HSHP
$729M
| $884K | ﹤0.01% |
153,147
-70,753
| -32% | -$395K |
|
|
BIOA
5032
BioAge Labs
BIOA
$928M
| $882K | ﹤0.01% |
213,503
+183,877
| +621% | +$741K |
|
|
TPIC
5033
DELISTED
TPI Composites
TPIC
| $880K | ﹤0.01% |
1,023,774
-97,302
| -9% | -$98.9K |
|
|
DGNX
5034
Diginex Ltd
DGNX
$43.9M
| $879K | ﹤0.01% |
17,089
+11,017
| +181% | +$831K |
|
5035
LCNB Corp
LCNB
$290M
| $877K | ﹤0.01% |
60,380
-10,573
| -15% | -$153K |
|
5036
Health Catalyst
HCAT
$159M
| $873K | ﹤0.01% |
231,589
+42,563
| +23% | +$167K |
|
5037
Savara
SVRA
$1.11B
| $872K | ﹤0.01% |
382,613
+127,100
| +50% | +$346K |
|
5038
ALPS Clean Energy ETF
ACES
$110M
| $870K | ﹤0.01% |
33,712
-8,905
| -21% | -$213K |
|
5039
OP Bancorp
OPBK
$232M
| $870K | ﹤0.01% |
66,944
+14,717
| +28% | +$179K |
|
5040
Euroseas
ESEA
$537M
| $870K | ﹤0.01% |
19,445
+13,841
| +247% | +$505K |
|
5041
Advantage Solutions
ADV
$504M
| $869K | ﹤0.01% |
26,346
+13,587
| +106% | +$448K |
|
5042
VanEck Israel ETF
ISRA
$152M
| $867K | ﹤0.01% |
16,720
-2,222
| -12% | -$101K |
|
5043
Vista Gold
VGZ
$253M
| $863K | ﹤0.01% |
884,817
-8,117
| -0.9% | -$7.92K |
|
|
FDIQ
5044
Invesco Bloomberg Financial Data Providers ETF
FDIQ
$52.5M
| $863K | ﹤0.01% |
14,930
-3,719
| -20% | -$204K |
|
5045
Claros Mortgage Trust
CMTG
$307M
| $860K | ﹤0.01% |
301,650
-150,323
| -33% | -$403K |
|
5046
BW LPG
BWLP
$3.2B
| $858K | ﹤0.01% |
72,491
+33,662
| +87% | +$358K |
|
5047
Dimensional International High Profitability ETF
DIHP
$6.22B
| $857K | ﹤0.01% |
29,065
-2,503
| -8% | -$70.4K |
|
5048
Barfresh Food Group
BRFH
$27.8M
| $857K | ﹤0.01% |
250,466
+51,240
| +26% | +$137K |
|
|
PHLT
5049
DELISTED
Performant Healthcare Inc
PHLT
| $856K | ﹤0.01% |
214,060
+85,654
| +67% | +$243K |
|
5050
Superior Group of Companies
SGC
$195M
| $854K | ﹤0.01% |
82,904
+6,994
| +9% | +$71.3K |
|
Similar funds
Morgan Stanley's Q2 2025 Portfolio in Review
As of Q2 2025, Morgan Stanley held 8,401 positions worth $1.54T, up 9.8% from $1.4T the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Morgan Stanley's Q2 2025 filing shows 313 new, 3,923 increased, 2,951 reduced and 306 closed positions. Its largest new stake was JBS N.V.: 7,554,358 shares worth $110M. The largest sale was UnitedHealth, an estimated $2.39B.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 20% a quarter earlier, followed by Financials and Consumer Discretionary.
- Morgan Stanley's largest Q2 2025 buy was JBS N.V.: 7,554,358 shares worth $110M.
- Morgan Stanley added most to Vanguard Short-Term Bond ETF in Q2 2025, an estimated $1.77B increase.
- Morgan Stanley's biggest Q2 2025 reduction was UnitedHealth, cutting an estimated $2.39B.
- Morgan Stanley fully exited Discover Financial Services in Q2 2025, selling an estimated $786M.
- Morgan Stanley's ten largest holdings make up 21% of its $1.54T portfolio in Q2 2025.
- Morgan Stanley opened 313 new positions and closed 306 in Q2 2025.
- Morgan Stanley's portfolio value rose 9.8% quarter-over-quarter to $1.54T.
Based on Morgan Stanley's 13F filing for Q2 2025, filed 15 Aug 2025.